STOK Competitors & Alternatives
Compare Stoke Therapeutics Inc with similar stocks in the same industry
Biotechnology
STOK
Main Stock$31.57
Tradestie Score
67
Market Cap
$1.29B
Revenue Growth
-1.0%
Analyst Upside
+42.9%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.45
|
$2.02B | 50.4 | 54 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$15.23
|
$2.01B | - | 56 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$36.54
|
$1.97B | - | 63 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$10.43
|
$1.92B | - | 57 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$90.74
|
$1.92B | - | 54 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$74.71
|
$1.90B | 418.1 | 55 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$37.70
|
$1.84B | - | 58 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.24
|
$1.81B | - | 64 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.71
|
$1.78B | - | 56 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$20.64
|
$1.78B | - | 62 | Compare |
More STOK Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry